Prevalence and determinants of unsuccessful tuberculosis treatment outcome among drug-susceptible tuberculosis patients in Rwanda

Author:

Gatete Gaetan1,Ruton Hinda1,Migambi Patrick2,Nshimiyimana Kizito1,Ntaganira Joseph1

Affiliation:

1. University of Rwanda

2. Rwanda Biomedical Centre

Abstract

Abstract Background Despite the effective diagnostic tools and treatment availability, tuberculosis (TB) remains the top cause of death as a single infectious disease worldwide. However, there is limited evidence on determinants of unsuccessful TB treatment outcome among drug-susceptible TB (DSTB) patients in Rwanda. Therefore, this study aimed to determine the determinants of unsuccessful TB treatment outcomes among adult DSTB patients in Rwanda. Methods A retrospective study was conducted among DSTB patients registered in the national electronic TB reporting system by all health facilities countrywide from July 2019 to June 2022. Patients aged 15 years and above with recorded treatment outcomes were included in the study. Multivariable logistic regression was performed using STATA 17 to determine factors associated with unsuccessful TB treatment outcomes. Adjusted odds ratio (OR), 95% confidence interval (CI), and p-value < 0.05 were reported. Results This study included 14,548 patients. Of them, 1527 (10.5%) patients had unsuccessful treatment outcome. In multivariate logistic regression analysis, not receiving ART (AOR = 4.3, 95% C.I:2.9–6.3), history of first-line TB treatment failure (AOR = 2.9, 95% C.I: 1.0-8.1), not being followed-up by community health workers (CHWs) (AOR = 1.6, 95% C.I:1.2–2.1), BMI < 18.5 at treatment initiation (AOR = 1.4, 95% C.I:1.1–1.8), extra-pulmonary TB (AOR = 0.5, 95% C.I:0.4–0.7), and clinically diagnosed (AOR = 0.4, 95% C.I:0.3–0.6), were found to be significantly associated with unsuccessful TB treatment outcome. Conclusion The study showed that unsuccessful TB treatment outcome among DSTB patients was low compared to studies conducted in other settings. This highlights a good progress in fighting against TB, but targeted strategies are still needed to address the remaining gap.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3